Neonatal intestinal obstruction
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Chronic obstructive asthma (with obstructive pulmonary disease)
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
4
|
1
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Deficiency of oxidase
|
disease |
|
Disease or Syndrome
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Myocardial rupture
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Meconium ileus
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
24
|
16
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
response to SSRI
|
phenotype |
|
Cell Function
|
28
|
53
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Atherosclerosis of aorta
|
phenotype |
Cardiovascular Diseases
|
Disease or Syndrome
|
37
|
1
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Circadian Rhythms
|
phenotype |
|
Organism Function
|
45
|
84
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Systolic blood pressure measurement
|
phenotype |
|
Diagnostic Procedure
|
54
|
95
|
0.100 |
None |
1.000 |
1 |
2
|
2018 |
2018 |
Body Weight
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organism Attribute
|
57
|
92
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Bipolar I disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
83
|
46
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Blood Pressure
|
phenotype |
|
Organism Function
|
109
|
220
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Organic Mental Disorders, Substance-Induced
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Atherothrombosis
|
disease |
|
Acquired Abnormality
|
115
|
15
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Prescription Drug Abuse
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Finding
|
115
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Drug Use Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
121
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Substance-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
128
|
20
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
NEUROTICISM
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
141
|
54
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Adult Liposarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
143
|
6
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Childhood Liposarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
143
|
6
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Mean blood pressure
|
phenotype |
|
Finding
|
146
|
344
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Substance Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
156
|
19
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Sarcopenia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
164
|
10
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Substance abuse problem
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
185
|
20
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Pediatric Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
191
|
67
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |